Levin M L, Kincaid M C, Eifler C W, Holt J E, Speights J W, O'Connor P S
Department of Ophthalmology, University of Texas Health Science Center, San Antonio.
J Cataract Refract Surg. 1988 Nov;14(6):642-9. doi: 10.1016/s0886-3350(88)80032-4.
We reviewed a series of 137 cataract extractions with intraocular lenses (IOLs) in patients with diabetes, mellitus between 1977 and 1983. All patients were followed for an average of 36 months to determine if they subsequently showed progression of diabetic retinopathy. Divided into groups according to the type of procedure and IOL received, they were compared for age, sex, duration of diabetes, treatment required for the diabetes, intraoperative complications, and follow-up period. Patients who had intracapsular cataract extractions with anterior chamber IOLs were three times as likely to show proliferative retinopathy as those who had extracapsular cataract extractions with posterior chamber IOLs. Insulin-dependent patients were three to four times more likely to show progression to proliferation than noninsulin dependent patients. We conclude that, while some procedures are riskier for the diabetic eye, extracapsular lens extraction with implantation of a posterior chamber lens does not imply an increased risk of development of proliferative retinopathy.
我们回顾了1977年至1983年间137例糖尿病患者行白内障摘除联合人工晶状体植入术的病例。所有患者平均随访36个月，以确定他们随后是否出现糖尿病视网膜病变进展。根据手术方式和所植入人工晶状体的类型分组，比较各组患者的年龄、性别、糖尿病病程、糖尿病所需治疗、术中并发症及随访时间。行囊内白内障摘除联合前房型人工晶状体植入术的患者发生增殖性视网膜病变的可能性是行囊外白内障摘除联合后房型人工晶状体植入术患者的三倍。胰岛素依赖型患者进展为增殖性病变的可能性是非胰岛素依赖型患者的三至四倍。我们得出结论，虽然某些手术对糖尿病眼风险更高，但囊外晶状体摘除联合后房型晶状体植入并不意味着增殖性视网膜病变发生风险增加。
